Dendritic Cell and Cancer Therapy
International Journal of Molecular Sciences · 20.02.2023 · 24 (4) · 4253
DOI: 10.3390/ijms24044253 ↗Kurz gefasst
Editorial in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.02.2023. Verfasst von Domenico Galati und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hematology-Oncology and Stem Cell Transplantation Unit, Department of Hematology and Innovative Diagnostic, Istituto Nazionale Tumori-IRCCS-Fondazion…. Hauptthemen laut MEDLINE: Dendritic Cells, Neoplasms. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Dendritic cells (DCs) are acknowledged as the most potent professional antigen-presenting cells (APCs), able to induce adaptive immunity and support the innate immune response [...]
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Hematology-Oncology and Stem Cell Transplantation Unit, Department of Hematology and Innovative Diagnostic, Istituto Nazionale Tumori-IRCCS-Fondazione "G. Pascale" Napoli, 80131 Napoli, Italy.
ORCID-Profile: Domenico Galati
Zitieren
APA
Galati, D., & Zanotta, S. (2023). Dendritic Cell and Cancer Therapy. International Journal of Molecular Sciences, 24(4), 4253. https://doi.org/10.3390/ijms24044253
Vancouver
Galati D, Zanotta S. Dendritic Cell and Cancer Therapy. International Journal of Molecular Sciences. 2023;24(4):4253. doi:10.3390/ijms24044253
BibTeX
@article{Galati2023,
author = {Galati, Domenico and Zanotta, Serena},
title = {Dendritic Cell and Cancer Therapy},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {4253},
doi = {10.3390/ijms24044253}
}
EUVIMED